Dr Scott O Trerotola (Hospital of the University of Pennsylvania, US) discusses the 24-month results from the LUTONIX AV IDE randomised trial.

Filmed by Radcliffe Vascular on-site at LINC 2019.

Editorial Team: Gary Swanston / David Ramsey 

Videographer: Tom Green

Questions:

1. What is the Lutonix AV IDE Trial and why was it needed? (00:10)

2. What was the design of the study and which patients were eligible? (00:33)

3. What are your findings? (01:12)

4. How should this trial influence practice? (02:24)

5. What future research if any is required?(03:00)